Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi‐institutional study in Taiwan
Cancer Cytopathology · 2024
DOI: 10.1002/cncy.22783 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Chun-Han Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Education, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan. Hauptthemen laut MEDLINE: Neoplasms, Pleural Effusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Ditmanson Medical Foundation Chia-Yi Christian Hospital.
Abstract (Originalsprache)
Background
The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was introduced globally in 2019 in response to the absence of a standardized reporting system for serous fluid cytology. This study presents experiences implementing this system across three distinct hospitals in Taiwan.
Methods
A total of 6177 serous fluid specimens in three hospitals in Taiwan between 2018 and 2020 were retrospectively reviewed and reclassified according to the ISRSFC. Cytohistological correlation and chart review were further performed to investigate etiologies and risks of malignancy (ROMs).
Results
Reclassification showed that 34 (0.7%) of 4838 pleural effusions were nondiagnostic (ND), 4086 (84.5%) were negative for malignancy (NFM), 201 (4.2%) were atypia of undetermined significance (AUS), 92 (1.9%) were suspicious for malignancy (SFM), and 425 (8.8%) were malignant (MAL). The 1231 ascites cases contained 13 (1.1%) ND, 1004 (81.6%) NFM, 53 (4.3%) AUS, 31 (2.5%) SFM, and 130 (10.6%) MAL specimens. In pleural effusions, the ROM was 2.9% for ND, 14.0% for NFM, 52.2% for AUS, 85.9% for SFM, and 95.1% for MAL. In ascites, it was 15.4% for ND, 19.1% for NFM, 52.8% for AUS, 83.9% for SFM, and 92.3% for MAL. In pericardial effusions, it was 0.0% for ND, 11.6% for NFM, 30.8% for AUS, 100.0% for SFM, and 95.2% for MAL. Different effusions' most common benign and malignant etiologies were also disclosed.
Conclusions
These multi‐institutional data have determined the diagnostic usefulness of the ISRSFC, which provides pathologists and physicians with invaluable assistance in correctly classifying effusions for further management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Education, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.
- Division of Pathology, Sijhih Cathay General Hospital, New Taipei City, Taiwan.
- Department of Pathology, Mackay Memorial Hospital, Taipei City, Taiwan.
- Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.
- PhD Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung City, Taiwan.
- Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan City, Taiwan.
ORCID-Profile: Chih-Yi Liu, Chien-Chin Chen
Förderung
- Ditmanson Medical Foundation Chia-Yi Christian Hospital
Zitieren
APA
Lu, C. H., Liu, C. Y., Jhuang, J. Y., & Chen, C. C. (2024). Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi‐institutional study in Taiwan. Cancer Cytopathology. https://doi.org/10.1002/cncy.22783
Vancouver
Lu CH, Liu CY, Jhuang JY, Chen CC. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi‐institutional study in Taiwan. Cancer Cytopathology. 2024. doi:10.1002/cncy.22783
BibTeX
@article{Lu2024,
author = {Lu, Chun-Han and Liu, Chih-Yi and Jhuang, Jie-Yang and Chen, Chien-Chin},
title = {Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi‐institutional study in Taiwan},
journal = {Cancer Cytopathology},
year = {2024},
doi = {10.1002/cncy.22783}
}
EUVIMED